Tetracycline-induced expression of an anti-c-Myb single-chain antibody and its inhibitory effect on proliferation of the human leukemia cell line K562

Cancer Gene Therapy

Volumn 7, Issue 1, 2000, Pages 151-159

  Kasono, Keizo ^a   Heike, Yuji ^a   Xiang, Jialing ^a   Piché, Alain ^b   Kim, Hyung Gyoon ^c   Kim, Myung ^a   Hagiwara, Masatoshi ^d   Nawrath, Michael ^e   Moelling, Karin ^e   Curiel, David T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c University of Alabama at Birmingham   (United States)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

C myb; Chronic myelogenous leukemia; Gene therapy; Oncogene; Single chain antibodies; Tetracycline inducible system

Indexed keywords

C MYB ANTIBODY; DOXYCYCLINE; PROTEIN ANTIBODY; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL STRAIN COS1; CELL STRAIN K 562; CELLULAR DISTRIBUTION; CHRONIC MYELOID LEUKEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; GENE THERAPY; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; TREATMENT OUTCOME;

ANIMALIA;

EID: 0033983519     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700117     Document Type: Article

References (50)

1. Klempnauer KH, Gonda TJ, Bishop JM. Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell. 1982;31:453-463.
2. Radke K, Beug H, Kornfeld S, et al. Transformation of both erythroid and myeloid cells by E26, an avian leukemia virus that contains myb gene. Cell. 1982;31:643-653.
3. Graf T. A transcriptional activator linking proliferation and differentiation in hematopoietic cells. Curr Opin Genet Dev. 1992-2:249-255.
4. Kanei-Ishii C, Nomura T, Ogawa K, et al. Structure and function of the proteins encoded by the myb gene family. Curr Top Microbiol Immunol 1996;211:89-98.
5. Luscher B, Eisenman N. New light on Myc and Myb. II. Myb. Genes Dev. 1990;4:2235-2241.
6. Shen-Ong GLC. The myb oncogene. Biochim Biophys Acta. 1990;1032:39-52.
7. Thompson MA, Ramsey RG. Myb: an old oncoprotein with new roles. Bioassays. 1995;17:341-350.
8. Duprey SP, Boettiger D. Developmental regulation of c-myb in normal myeloid progenitor cells. Proc Natl Acad Sci USA. 1985;82:6937-6941.
9. Gonda TJ, Metcalf D. Expression of myb, myc, and fos proto-oncogenes during the differentiation of a murine myeloid leukemia. Nature. 1984;310:249-251.
10. Sheiness D, Gardinier M. Expression of a proto-oncogene (proto-myb) in hemopoietic tissue of mice. Mol Cell Biol. 1984;4:1206-1212.
11. Torelli G, Venturelli D, Colo A, et al. Expression of c-myb protooncogene and other cell cycle-related genes in normal and neoplastic human colonic mucosa. Cancer Res. 1987;47:5266-5269.
12. Thiele CJ, Cohen PS, Israel MA. Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation. Mol Cell Biol. 1988;8:1677-1683.
13. Dyson PJ, Poirier F, Watson RJ. Expression of c-myb in embryonal carcinoma cells and embryonal stem cells. Differentiation. 1989;42:24-27.
14. Westin EH, Wong-Staal F, Gelmann EP, et al. Expression of cellular homologues of retroviral one genes in human hematopoietic cells. Proc Natl Acad Sci USA. 1982;79: 2490-2494.
15. Craig RW, Bloch A. Early decline in c-myb oncogene expression in the differentiation of human myeloblastic leukemia (ML-1) cells induced with 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1984;44:442-446.
16. Slamon DJ, DeKernion JB, Verma IM, et al. Expression of cellular oncogenes in human malignancies. Science. 1984; 224:256-262.
17. Slamon DJ, Boone TC, Murdock DC, et al. Studies of the human c-myb gene and its product in human acute leukemias. Science. 1986;233:347-354.
18. Mavilio F, Sposi NM, Petrini M, et al. Expression of cellular oncogenes in primary cells from human acute leukemias. Proc Natl Acad Sci USA. 1986;83:4394-4398.
19. Bading H, Gerdes J, Schwarting R, et al. Nuclear and cytoplasmic distribution of cellular myb protein in human hematopoietic cells as evidenced by monoclonal antibody. Oncogene. 1988;3:257-265.
20. Thiele CJ, McKeon C, Triche TJ, et al. Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J Clin Invest. 1987;80:804-811.
21. Thiele CJ, Cohen PS, Israel MA. Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation. Mol Cell Biol. 1988;8:1677-1683.
22. Griffin CA, Baylin SB. Expression of the c-myb oncogene in human small cell lung carcinoma. Cancer Res. 1985;45: 272-275.
23. Alitalo K, Winrvist R, Lin CC, De La Chapelle A, Schwab M, Bishop JM. Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. Proc Natl Acad Sci USA. 1984;81:4534-4538.
24. McClinton D, Stafford J, Brents L, et al. Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene. Mol Cell Biol. 1990;10:705-710.
25. Clarke MF, Kukowski-Latallo JF, Westin E, et al. Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol Cell Biol. 1988;8: 884-892.
26. Todokoro K, Watson J, Higo H, et al. Down-regulation of c-myb gene expression is a prerequisite for erythropoietin-induced erythroid differentiation. Proc Natl Acad Sci USA. 1988;85:8900-8904.
27. Grasser FA, Graf T, Lipsick JS. Protein truncation is required for activation of the c-myb proto-oncogene. Mol Cell Biol. 1991;11:3987-3996.
28. Gonda TJ, Buckmaster C, Ramsay RG. Activation of c-myb by carboxyl-terminal truncation: relationship to transformation of murine haematopoietic cells in vitro. EMBO J. 1989;8:1777-1783.
29. Fu SL, Lipsick JS. Constitutive expression of full-length c-Myb transforms avian cells characteristic of both the monocytic and granulocytic lineages. Cell Growth Differ. 1997;8:35-45.
30. Anfossi G, Gewirtz AM, Calabretta B. An oligomer complementary to c-myfo-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc Natl Acad Sci USA. 1989;86:3379-3383.
31. Calabretta B, Smis RB, Valtieri M, et al. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Proc Natl Acad Sci USA. 1991;88:2351-2355.
32. Wolff L. Myb-induced transformation. Crit Rev Oncog. 1996;7:245-260.
33. Kasono K, Pichè A, Xiang J, et al. Functional knock-out of c-myb by an intracellular anti-c-Myb single-chain antibody. Biochem Biophys Res Commun. 1998;251:124-130.
34. + cells and CML mononuclear cells. Stem Cells. 1997;15: 386-395.
35. Brenner MK. Hematological malignancies. FASEB J. 1997; 11:640-648.
36. Watsuji T, Okamoto Y, Emi N, et al. Controlled gene expression with a reverse tetracycline-regulated retroviral vector (RTRV) system. Biochem Biophys Res Commun. 1997;234:769-773.
37. Bading H, Beutler C, Beimling J, et al. Monoclonal antibodies against the viral and human cellular myb gene product. Hamatol Bluttransfus. 1987;31:488-492.
38. Kalderon D, Roberts BL, Richardson WD, et al. A short amino acid sequence able to specify nuclear location. Cell 1984;39:499-509.
39. Miller AD, Rosman GH. Improved retroviral vector for gene transfer and expression. Biotechniques. 1989;7:980-990.
40. Cormack BP, Valdivia R, Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene. 1996;173:33-38.
41. Curiel DT. High-efficiency gene transfer employing adenovirus-polylysine-DNA complexes. Nat Immun. 1994;13: 141-164.
42. Grim J, Deshane J, Feng M, et al. ErbB-2 knockout employing an intracellular single-chain antibody (sFv) accomplishes specific toxicity in erbB-2-expressing lung cancer cells. Am J Respir Cell Mol Biol. 1996;15:348-354.
43. Zobel A, Kalkbrenner F, Vorbrueggen G, et al. Transactivation of the human c-myc gene by c-myb. Biochem Biophys Res Commun. 1992;186:715-722.
44. Kim HG, Miller DM. Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter. Biochemistry. 1995;34:8165-8171.
45. Iida A, Chen ST, Friedmann T, et al. Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system. J Virol. 1996;70:6054-6059.
46. Yu JS, Sena-Esteves M, Paulus W, et al. Retroviral delivery and tetracycline-dependent expression of IL-1β-converting enzyme (ICE) in a rat glioma model provides controlled induction of apoptotic death in tumor cells. Cancer Res. 1996;56:5423-5427.
47. Ratajczak MZ, Kant JA, Luger SM, et al. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci USA. 1992;89:11823-11827.
48. Hijiya N, Zhang J, Ratajczak MZ, et al. Biologic and therapeutic significance of MYB expression in human melanoma. Proc Natl Acad Sci USA. 1994;91:4499-4503.
49. Dmitriev I, Krasnykh V, Miller CR, et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol. 1998;72:9706-9713.
50. Suzuki T, Piche A, Kasono K, et al. Efficient gene delivery into Epstein-Barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): a gene therapy model for EBV-related B cell malignancy. Biochem Biophys Res Commun. 1998;252:686-690.